What is the recommended dosage of acyclovir (Antiviral medication) for the treatment of zoster (Shingles)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Acyclovir Dosing for Zoster (Shingles)

For the treatment of herpes zoster (shingles), acyclovir should be administered at a dose of 800 mg orally five times daily for 7-10 days. 1, 2

Recommended Dosing Regimen

  • First-line treatment: Acyclovir 800 mg orally 5 times daily for 7-10 days 2, 3
  • Treatment should be initiated as soon as possible after symptom onset, ideally within 72 hours of rash appearance 3, 4
  • For children: Acyclovir 20 mg/kg body weight orally per dose (maximum 800 mg/dose) 4 times daily for 7-10 days or until no new lesions appear for 48 hours 2

Alternative Antiviral Options

If acyclovir is not tolerated or available, alternative options include:

  • Valacyclovir: 1,000 mg orally 3 times daily for 7 days 5

    • Offers simpler dosing schedule with comparable efficacy
    • Better bioavailability than acyclovir (3-5 times higher)
  • Famciclovir: 500 mg orally 3 times daily for 7 days 6

    • Approved for adults and adolescents with zoster

Special Populations

Severe Immunosuppression

  • For patients with severe immune suppression (CDC immunologic category 3), intravenous acyclovir is recommended 2

Renal Impairment

  • Dose adjustment required for creatinine clearance <50 mL/min 1
  • Maintain adequate hydration during treatment to minimize nephrotoxicity risk

Ophthalmic Zoster (Zoster Ophthalmicus)

  • Same dosing regimen applies, but involvement of an experienced ophthalmologist is strongly recommended 2
  • For persistent or recalcitrant disease, oral antivirals at the standard dose are beneficial 2

Clinical Pearls and Pitfalls

  • Timing matters: Initiating treatment within 72 hours of rash onset provides maximum benefit for reducing acute pain and preventing postherpetic neuralgia 3, 4
  • Duration of therapy: Treatment should continue for 7-10 days or until no new lesions appear for 48 hours 2
  • Pain management: Antiviral therapy reduces the duration of zoster-associated pain from an average of 86 days to 49 days 3
  • Monitoring: Follow patients for resolution of skin lesions and pain; consider extended therapy if healing is incomplete after 10 days
  • Common side effects: Gastrointestinal symptoms (nausea, vomiting, diarrhea) are the most common adverse effects 7

Treatment Algorithm

  1. Confirm diagnosis of herpes zoster
  2. Assess timing of rash onset (ideally <72 hours)
  3. Evaluate immune status of patient
  4. For immunocompetent patients: Start acyclovir 800 mg orally 5 times daily for 7-10 days
  5. For severely immunosuppressed patients: Consider IV acyclovir
  6. For ophthalmic involvement: Consult ophthalmology while initiating treatment
  7. Monitor for clinical response and consider extending therapy if healing is incomplete

Remember that early treatment is crucial for reducing pain, speeding healing, and preventing complications such as postherpetic neuralgia.

References

Guideline

Herpes Simplex Virus Infections Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Zoster-associated chronic pain: an overview of clinical trials with acyclovir.

Scandinavian journal of infectious diseases. Supplementum, 1991

Research

Therapy of herpes zoster with oral acyclovir.

The American journal of medicine, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.